2021
DOI: 10.1097/jcp.0000000000001512
|View full text |Cite
|
Sign up to set email alerts
|

Decrease in Antidepressant Efficacy After Change in Generic Formulation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 18 publications
0
2
0
Order By: Relevance
“…However, proof of bioequivalence does not necessarily establish equivalence in clinical outcomes (efficacy and/or toxicity) of generic and brand‐name drugs, including psychotropics 1 , 2 . The following case describes a clinical problem that appeared to be associated with a change in generic formulations of an antidepressant in an elderly patient 3 …”
mentioning
confidence: 99%
See 1 more Smart Citation
“…However, proof of bioequivalence does not necessarily establish equivalence in clinical outcomes (efficacy and/or toxicity) of generic and brand‐name drugs, including psychotropics 1 , 2 . The following case describes a clinical problem that appeared to be associated with a change in generic formulations of an antidepressant in an elderly patient 3 …”
mentioning
confidence: 99%
“…1,2 The following case describes a clinical problem that appeared to be associated with a change in generic formulations of an antidepressant in an elderly patient. 3…”
mentioning
confidence: 99%